Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Carcinoma × osimertinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 152 Lung Neoplasms 48 Neoplasms 13 NSCLC 11 Neoplasm Metastasis 10 Brain Neoplasms 10 Carcinoma 8 Meningeal Carcinomatosis 6 Bronchial Neoplasms 5 Thoracic Neoplasms 4 Colorectal Neoplasms 4 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Neoplasms by Site 3 Lung Diseases 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Noonan Syndrome 2 Non Small Cell Lung Cancer Metastatic 2 Neoplasms, Nerve Tissue 2 Neoplasms by Histologic Type 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Bronchogenic 2 Breast Neoplasms 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡